Abstract
Regulations are making it more difficult to provide innovative treatments for our patients. Deregulation of the healthcare industry and the US Food and Drug Administration (FDA) would likely save lives and cost much less. The public needs to take some responsibility for their own healthcare. The FDA has the responsibility to release all relevant supporting information after approval of a device. Quackery is rampant within the aesthetic world.
Originally presented as the Leon Goldman, M.D. Memorial Lectureship Award lecture at the 29th Annual Conference, April 1–5, 2009, National Harbor, MD
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Campbell ND. Replace FDA regulation of medical devices with third-party certification. CATO INST. POL’Y ANALYSIS (Nov. 12, 1997).
Christopher J. Health care regulation; A $169 billion hidden tax. Conover policy analysis; 2004.
Higgs R. How FDA is causing a technological exodus: a comparative analysis of medical device regulation – United States, Europe, Canada, and Japan. Washington: Competitive Enterprise Institute.
Institute of Medicine. Care without coverage: Too little, too late. Washington DC: Institute of Medicine, 2002.
The cost of federal regulation of economic activity. Washington: American Enterprise Institute; 1978.
Why ‘quality’ care is dangerous. Wall St J. 2009.
Timio M. The urologic tradition of Preci. Am J Nephrol. 1994;14(4–6):473–6.
Duncanson E, Richards V, Luce KM, Gill JR. Medical homicide and extreme negligence. Am J Forensic Med Pathol. 2009;30(1):18–22.
Dang JM, Krause D, Felten RP, Luke MC. Medical device regulation: What a practicing dermatologist should know. Dermatol Ther. 2009;22:241–45.
Chertow DS, Tan ET, Maslanka SE, Schulte J, Bresnitz EA, Weisman RS, Bernstein J, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA. 2006;296(20):2476–9.
NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.
Torbenson M, Erlen J. A quantitative profile of the patent medicine industry in Baltimore from 1863 to 1930. Pharm Hist. 2007;49(1):15–27.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zachary, C.B. (2011). The Business of Laser Surgery. In: Raulin, C., Karsai, S. (eds) Laser and IPL Technology in Dermatology and Aesthetic Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03438-1_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-03438-1_31
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03437-4
Online ISBN: 978-3-642-03438-1
eBook Packages: MedicineMedicine (R0)